Affiliation:
1. University of Helsinki
Abstract
Abstract
Preeclampsia is a common multifactorial disease of pregnancy. Dysregulation of the complement activation is among emerging candidates responsible for disease pathogenesis. In a targeted exomic sequencing study we identified 14 variants within nine genes coding for components of the membrane attack complex (MAC, C5b-9) that are associated with preeclampsia. We found two rare missense variants in the C5 gene that predispose to preeclampsia (rs200674959: I1296V, OR (CI95) = 24.13 (1.25–467.43), p-value = 0.01 and rs147430470: I330T, OR (CI95) = 22.75 (1.17–440.78), p-value = 0.01). In addition, one predisposing rare variant and one protective rare variant were discovered in C6 (rs41271067: D396G, OR (CI95) = 2.93 (1.18–7.10), p-value = 0.01 and rs114609505: T190I, 0.02 OR (CI95) = 0.47 (0.22–0.92), p-value = 0.02). The results suggest that variants in terminal complement pathway predispose to preeclampsia.
Publisher
Research Square Platform LLC
Reference37 articles.
1. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease;Lisonkova S;Am J Obstet Gynecol,2013
2. Global and regional estimates of preeclampsia and eclampsia: a systematic review;Abalos E;European Journal of Obstetrics & Gynecology and Reproductive Biology,2013
3. Van Lerberghe W, Manuel A, Matthews Z, Cathy W. The World Health Report 2005 - make every mother and child count. World Health Organization; 2005.
4. The global impact of pre-eclampsia and eclampsia;Duley L;Semin Perinatol,2009
5. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension;Salonen Ros H;Am J Med Genet,2000